Evidence mapPaperPMID 40825848Full record

ArticleScientific reports2025

Artificial intelligence-assisted optimization of Eichhornia crassipes extracts and evaluation of their biological activities.

Nuh Korkmaz

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Nuh KorkmazFaculty of Engineering and Natural Sciences, Department of Biology, Osmaniye Korkut Ata University, Osmaniye, Türkiye. korkmazhun@gmail.com.ORCID http://orcid.org/0000-0001-8299-910X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this research, the extraction conditions for Eichhornia crassipes (Mart.) Solms were optimized using Response Surface Methodology (RSM) and Artificial Neural Network-Genetic Algorithm (ANN-GA) techniques to enhance the biological efficacy of the extracts. The optimization focused on three key variables: extraction temperature, duration, and the ethanol-to-water solvent ratio. Through the ANN-GA model, the optimal parameters were identified as 56.85 °C for temperature, 7.62 h for extraction time, and 23.93% for the ethanol/water proportion. The obtained extracts showed statistically significantly higher values ​​compared to RSM in terms of antioxidant capacity (FRAP: 152.89 mg TE/g; DPPH: 121.48 mg TE/g), total phenolic content (TPC: 209.47 mg GAE/g) and flavonoid content (TFC: 263.86 mg QE/g). In addition, ANN-GA extract exhibited high anticholinesterase activity with lower IC₅₀ values ​​against acetylcholinesterase (AChE: 61.69 µg/mL) and butyrylcholinesterase (BChE: 81.40 µg/mL) enzymes. In in vitro tests on A549 cell line, its antiproliferative effect increased significantly in a dose-dependent manner and significant decreases in cell viability were observed especially at high concentrations. LC-MS/MS analyses revealed that pharmacologically important phenolic compounds such as quercetin (10295.26 mg/kg), kaempferol (8656.31 mg/kg) and naringenin (5364.56 mg/kg) were present in high concentrations in the optimized extracts. In conclusion, ANN-GA based extraction approach stands out as an effective method for obtaining phenolic compound rich and biologically effective extracts of E. crassipes. These findings indicate that this aquatic plant should be evaluated for its pharmaceutical, neuroprotective and anticancer potential.

Indexed as

Artificial IntelligenceEichhorniaPlant ExtractsAcetylcholinesteraseAntioxidantsCell Line, TumorCell SurvivalCholinesterase InhibitorsFlavonoidsHumansNeural Networks, ComputerPhenolsAcetylcholinesteraseAntioxidantsCholinesterase InhibitorsFlavonoidsPhenolsPlant ExtractsANN-GAAnticholinesterase effectAntioxidant activityAntiproliferative activityEichhornia crassipesExtraction optimizationPhenolic compounds

Identifiers

PMID40825848
PMCPMC12361514

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.